Insider Buy/Sell Details for the Healthcare Sector — Last 7 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (232)
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
5,656
Price
$84.90
Total Value
$480.20K
Shares Held After
15,612
% of Holdings
26.6%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
3,743
Price
$84.26
Total Value
$315.37K
Shares Held After
21,268
% of Holdings
15.0%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
300
Price
$83.07
Total Value
$24.92K
Shares Held After
25,011
% of Holdings
1.2%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
18
Price
$303.03
Total Value
$5.45K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
136
Price
$302.19
Total Value
$41.10K
Shares Held After
18
% of Holdings
88.3%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
150
Price
$301.18
Total Value
$45.18K
Shares Held After
154
% of Holdings
49.3%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
370
Price
$300.12
Total Value
$111.04K
Shares Held After
304
% of Holdings
54.9%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
5,143
Price
$298.94
Total Value
$1.54M
Shares Held After
674
% of Holdings
88.4%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
3,074
Price
$298.35
Total Value
$917.13K
Shares Held After
5,817
% of Holdings
34.6%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
1,314
Price
$297.23
Total Value
$390.56K
Shares Held After
8,891
% of Holdings
12.9%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
1,493
Price
$296.07
Total Value
$442.03K
Shares Held After
10,205
% of Holdings
12.8%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
15,102
Price
$8.97
Total Value
$135.46K
Shares Held After
16,811,021
% of Holdings
0.1%
4D Molecular Therapeutics, Inc. (FDMT)
Kirn David — Director
Shares
442
Price
$12.84
Total Value
$5.67K
Shares Held After
884,152
% of Holdings
0.0%
4D Molecular Therapeutics, Inc. (FDMT)
Kirn David — Director
Shares
15,283
Price
$12.01
Total Value
$183.56K
Shares Held After
884,594
% of Holdings
1.7%
Alignment Healthcare, Inc. (ALHC)
KAO JOHN E — Director
Shares
18,356
Price
$20.65
Total Value
$379.00K
Shares Held After
1,088,766
% of Holdings
1.7%
Alignment Healthcare, Inc. (ALHC)
KAO JOHN E — Director
Shares
279,644
Price
$19.81
Total Value
$5.54M
Shares Held After
1,107,122
% of Holdings
20.2%
CG Oncology, Inc. (CGON)
Mulay James — Director
Shares
24,165
Price
$75.16
Total Value
$1.82M
Shares Held After
0
% of Holdings
100.0%
Bicara Therapeutics Inc. (BCAX)
Mazumdar Claire — Director
Shares
28
Price
$29.68
Total Value
$831.04
Shares Held After
362,152
% of Holdings
0.0%
Bicara Therapeutics Inc. (BCAX)
Mazumdar Claire — Director
Shares
9,972
Price
$28.42
Total Value
$283.37K
Shares Held After
362,180
% of Holdings
2.7%
HEALTHEQUITY, INC. (HQY)
Fiore Michael Henry — EVP, CHIEF COMMERCIAL OFFICER
Shares
2,354
Price
$95.00
Total Value
$223.63K
Shares Held After
52,244
% of Holdings
4.3%
SOPHiA GENETICS SA (SOPH)
Camblong Jurgi — Director
Shares
8,500
Price
$5.62
Total Value
$47.79K
Shares Held After
3,532,622
% of Holdings
0.2%
Pennant Group, Inc. (PNTG)
Guerisoli Brent — Chief Executive Officer
Shares
3,159
Price
$41.56
Total Value
$131.30K
Shares Held After
103,829
% of Holdings
3.0%
Heartflow, Inc. (HTFL)
Farquhar John C.M. — Director
Shares
22,562
Price
$27.75
Total Value
$626.10K
Shares Held After
435,373
% of Holdings
4.9%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
43,367
Price
$2.43
Total Value
$105.38K
Shares Held After
2,741,892
% of Holdings
1.6%
Arcus Biosciences, Inc. (RCUS)
Jaen Juan C. — President
Shares
268
Price
$29.40
Total Value
$7.88K
Shares Held After
822,240
% of Holdings
0.0%
Arcus Biosciences, Inc. (RCUS)
Jaen Juan C. — President
Shares
19,799
Price
$28.61
Total Value
$566.41K
Shares Held After
822,508
% of Holdings
2.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$553.47
Total Value
$44.28K
Shares Held After
40,513
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$548.44
Total Value
$219.38K
Shares Held After
40,593
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,578
Price
$547.17
Total Value
$863.44K
Shares Held After
40,993
% of Holdings
3.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,438
Price
$546.42
Total Value
$785.75K
Shares Held After
42,571
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,524
Price
$545.54
Total Value
$831.41K
Shares Held After
44,009
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
364
Price
$544.54
Total Value
$198.21K
Shares Held After
45,533
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
676
Price
$543.34
Total Value
$367.30K
Shares Held After
45,897
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,870
Price
$542.49
Total Value
$1.01M
Shares Held After
46,573
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
970
Price
$541.47
Total Value
$525.23K
Shares Held After
48,443
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
600
Price
$540.37
Total Value
$324.22K
Shares Held After
49,413
% of Holdings
1.2%
NEUROCRINE BIOSCIENCES INC (NBIX)
Delaet Ingrid — Chief Regulatory Officer
Shares
4,367
Price
$181.02
Total Value
$790.51K
Shares Held After
16,225
% of Holdings
21.2%
Indivior Pharmaceuticals, Inc. (INDV)
Heidbreder Christian — Chief Scientific Officer
Shares
18,586
Price
$41.14
Total Value
$764.63K
Shares Held After
209,337
% of Holdings
8.2%
Amylyx Pharmaceuticals, Inc. (AMLX)
Mazzariello Gina — Chief Legal Officer
Shares
15,000
Price
$17.61
Total Value
$264.12K
Shares Held After
179,090
% of Holdings
7.7%
RedHill Biopharma Ltd. (RDHL)
Raday Gilead — Chief Operating Officer
Shares
14,130,000
Price
$0.00
Total Value
$1.41K
Shares Held After
218,780,000
% of Holdings
6.1%
Bluejay Diagnostics, Inc. (BJDX)
HRT FINANCIAL LP — 10% Owner
Shares
34,938
Price
$1.40
Total Value
$48.91K
Shares Held After
92,055
% of Holdings
27.5%
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
HRT FINANCIAL LP — 10% Owner
Shares
731
Price
$3.11
Total Value
$2.27K
Shares Held After
61,271
% of Holdings
1.2%
ADIAL PHARMACEUTICALS, INC. (ADIL)
Coastlands Capital LP — 10% Owner
Shares
1,700
Price
$2.70
Total Value
$4.59K
Shares Held After
385,075
% of Holdings
0.4%
Anixa Biosciences Inc (ANIX)
KUMAR AMIT — Director
Shares
5,000
Price
$3.04
Total Value
$15.20K
Shares Held After
635,812
% of Holdings
0.8%
Taysha Gene Therapies, Inc. (TSHA)
Nagendran Sukumar — Director
Shares
200,000
Price
$6.24
Total Value
$1.25M
Shares Held After
936,410
% of Holdings
17.6%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
1,000
Price
$0.94
Total Value
$940.00
Shares Held After
369,485
% of Holdings
0.3%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
229
Price
$73.95
Total Value
$16.93K
Shares Held After
492,241
% of Holdings
0.0%
Edwards Lifesciences Corp (EW)
Lippis Daniel J. — CVP, TAVR
Shares
619
Price
$91.70
Total Value
$56.76K
Shares Held After
40,034
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
MALCOLM JAN — Director
Shares
325
Price
$550.59
Total Value
$178.94K
Shares Held After
450
% of Holdings
41.9%
VIVOS INC (RDGL)
Weeks Brad Allan — President
Shares
12,000
Price
$0.08
Total Value
$960.00
Shares Held After
999,235
% of Holdings
1.2%
Showing 151–200 of 232 transactions (page 4 of 5)